We are live on ! Find out more
AGN.PRA

Allergan plc

Delisted

AGN.PRA was delisted on the 28th of February, 2018.

103 hedge funds and large institutions have $3.64B invested in Allergan plc in 2016 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 34 increasing their positions, 35 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 13

1% more funds holding

Funds holding: 102103 (+1)

0% more funds holding in top 10

Funds holding in top 10: 1111 (0)

3% less repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 35

13% less capital invested

Capital invested by funds: $4.18B → $3.64B (-$542M)

Holders
103
Holders Change
+1
Holders Change %
+0.98%
% of All Funds
2.73%
Holding in Top 10
11
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.29%
New
14
Increased
34
Reduced
35
Closed
13
Calls
Puts
Net Calls
Net Calls Change

AGN.PRA Hedge Fund Activity: Q1 2016 in Review

103 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN.PRA) for Q1 2016, worth a combined $3.64B — down 13% from $4.18B a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new AGN.PRA positions and 13 closed out — a net gain of 1 holder — while 34 added to existing stakes and 35 trimmed.

The largest buyer was Discovery Capital Management, opening a new position worth an estimated $181M. The largest seller was AQR Arbitrage, exiting entirely with an estimated $211M sold.

  • 103 institutional investors held Allergan plc (AGN.PRA) as of Q1 2016, up from 102 in Q4 2015.
  • Funds reported $3.64B of Allergan plc stock for Q1 2016, down 13% quarter-over-quarter.
  • 14 funds opened new Allergan plc positions in Q1 2016 and 13 closed out, a net change of +1 holder.
  • The largest Allergan plc buyer in Q1 2016 was Discovery Capital Management, an estimated $181M added.
  • The largest Allergan plc seller in Q1 2016 was AQR Arbitrage, an estimated $211M sold.

Based on aggregated 13F filings for Q1 2016.